SINGLE DOMAIN ANTIBODIES FOR DETECTION AND IMAGING OF MODIFIED RNA NUCLEOSIDES
Award amount
$249,946Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- VITAN-BIOTECH LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- ML5NLF9L1FP9
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Field-Deployable, low-Cost Point-of-Need urine test strips for mobile quantification of SUD medication drugs and their metabolites
- Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
- Plasmonic Glycan Arrays for Highly Sensitive Detection of Glycan-binding Proteins
- Development of safe and effective immunotherapeutics for treatment of opioid abuse and overdose
- Developing high-affinity nanobodies to tumor-associated glycan antigens
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
9 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $1,791,537. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services